SCHEMBL23202794

SCHEMBL23202794

COCOc1cc(OCOC)c2c(c1)OC(c1ccc(OC)c(O)c1)C(O)C2=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.62
▸ XDH P47989 3/20 0.55
▸ ACHE P22303 1/20 0.52
▸ ROR1 Q01973 1/20 0.51
▸ CYP2C9 P11712 4/20 0.47
▸ SLCO1B3 Q9NPD5 4/20 0.47
▸ SLCO1B1 Q9Y6L6 4/20 0.47
▸ CYP3A4 P08684 3/20 0.47
▸ ALOX15 P16050 3/20 0.47
▸ SLCO2B1 O94956 3/20 0.47
▸ MAPT P10636 2/20 0.47
▸ HPGD P15428 2/20 0.47
▸ HSD17B10 Q99714 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ ALOX12 P18054 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ F2 P00734 1/20 0.47
▸ PLAU P00749 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30350332 1.00 ALDH1A1 (0.62) ALDH1A1XDHACHEROR1CYP2C9
SCHEMBL31162964 0.92 ALDH1A1 (0.71) ALDH1A1XDHACHEROR1CYP2C9
SCHEMBL31162814 0.87 ALDH1A1 (0.57) ALDH1A1XDHROR1CYP3A4MAPT
SCHEMBL31162789 0.82 ALDH1A1 (0.54) ALDH1A1XDHROR1SYNJ2
SCHEMBL30576357 0.82 ALDH1A1 (0.54) ALDH1A1XDHROR1SYNJ2
SCHEMBL28302550 0.82 ALDH1A1 (0.71) ALDH1A1XDHACHECYP2C9SLCO1B3
SCHEMBL28213500 0.82 ALDH1A1 (0.71) ALDH1A1XDHACHECYP2C9SLCO1B3
SCHEMBL28320416 0.81 ALDH1A1 (0.56) ALDH1A1XDHCYP2C9SLCO1B3SLCO1B1
SCHEMBL31162753 0.80 ALDH1A1 (0.53) ALDH1A1XDHROR1KDM4EMEN1
SCHEMBL28321479 0.80 CYP3A4 (0.59) ALDH1A1ROR1CYP3A4ALOX15MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11643405-B2 Compound for treatment or prevention of liver diseases JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO., LTD. (CN) 2023-05-09 — — US disclosed
US-20210246126-A1 COMPOUND FOR TREATMENT OR PREVENTION OF LIVER DISEASES JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO., LTD. (CN) 2021-08-12 — — US disclosed
EP-3805216-A1 COMPOUNDS FOR TREATMENT OR PREVENTION OF LIVER DISEASES Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd. (CN) 2021-04-14 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210246126-A1 COMPOUND FOR TREATMENT OR PREVENTION OF LIVER DISEASES SLC10A1, GYS2, CPT1A ALDH1A1 164/4885XDH 137/4885ACHE 726/4885
US-11643405-B2 Compound for treatment or prevention of liver diseases SLC10A1, GYS2, CPT1A ALDH1A1 164/4885XDH 137/4885ACHE 726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback